Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes

Standl E, Schnell O

PRIMÄR Tier 2 2012

StudiedesignPRIMÄR

TierTier 2, Strong human evidence, hard endpoints or biomarkers

År2012

TidskriftCardiovasc Diabetol

Tillagd i NO1GEVITYmaj 27, 2026

Citerad av

1 encyklopediartiklar refererar till denna studie.